Efficacy and safety of newly developed cross-linked dextran gel injection for glans penis augmentation with a novel technique

Dae Yul Yang, Kyungtae Ko, Seong Ho Lee, Du Geon Moon, Jong Wook Kim, Won Ki Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

There is no safe and effective standard method for glans penis augmentation. Furthermore, there has been scant research on glans penis augmentation due to a poor understanding of glans anatomy, technical difficulty, and a lack of suitable substances for augmentation. Cross-linked dextran gel is a newly developed filler for soft-tissue augmentation. We evaluated the efficacy and safety of using a novel technique to inject cross-linked dextran gel for glans penis augmentation during a 24-week follow-up study. This prospective, single-arm, multicenter study enrolled twenty healthy adult men who underwent glans penis augmentation between June and August 2013. Cross-linked dextran gel was injected into the glans penis using a simple and easy technique. The sizes of the glans penis and individual satisfaction were assessed. Any adverse event was also reported. A total of 18 individuals were analyzed; two of them were lost to follow-up. The mean procedure time and injected volume were about 30 min and 6.6 ± 0.9 ml, respectively. The mean surface areas of the glans at baseline and 24 weeks were 20.0 ± 3.5 cm2 and 33.6 ± 5.4 cm2, respectively, representing a mean increase of 68.7% ± 14.0% (P < 0.001). Sixteen individuals (88.9%) were satisfied with the outcomes, and none were dissatisfied. There were no serious adverse events during the study. Cross-linked dextran gel injection for glans penis augmentation was easy and showed a significant augmentative effect on the glans penis, good durability, and was well tolerated without serious adverse events. Therefore, cross-linked dextran gel injection may be an effective, new technique for glans penis augmentation.

Original languageEnglish
Pages (from-to)80-84
Number of pages5
JournalAsian Journal of Andrology
Volume20
Issue number1
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Penis
Dextrans
Gels
Safety
Injections
Lost to Follow-Up
Multicenter Studies
Anatomy

Keywords

  • cosmetic technique
  • dermal fllers
  • dextran
  • glans penis

ASJC Scopus subject areas

  • Urology

Cite this

Efficacy and safety of newly developed cross-linked dextran gel injection for glans penis augmentation with a novel technique. / Yang, Dae Yul; Ko, Kyungtae; Lee, Seong Ho; Moon, Du Geon; Kim, Jong Wook; Lee, Won Ki.

In: Asian Journal of Andrology, Vol. 20, No. 1, 01.01.2018, p. 80-84.

Research output: Contribution to journalArticle

Yang, Dae Yul ; Ko, Kyungtae ; Lee, Seong Ho ; Moon, Du Geon ; Kim, Jong Wook ; Lee, Won Ki. / Efficacy and safety of newly developed cross-linked dextran gel injection for glans penis augmentation with a novel technique. In: Asian Journal of Andrology. 2018 ; Vol. 20, No. 1. pp. 80-84.
@article{1e529cc2d43d4bdc807cf6b58b144b4e,
title = "Efficacy and safety of newly developed cross-linked dextran gel injection for glans penis augmentation with a novel technique",
abstract = "There is no safe and effective standard method for glans penis augmentation. Furthermore, there has been scant research on glans penis augmentation due to a poor understanding of glans anatomy, technical difficulty, and a lack of suitable substances for augmentation. Cross-linked dextran gel is a newly developed filler for soft-tissue augmentation. We evaluated the efficacy and safety of using a novel technique to inject cross-linked dextran gel for glans penis augmentation during a 24-week follow-up study. This prospective, single-arm, multicenter study enrolled twenty healthy adult men who underwent glans penis augmentation between June and August 2013. Cross-linked dextran gel was injected into the glans penis using a simple and easy technique. The sizes of the glans penis and individual satisfaction were assessed. Any adverse event was also reported. A total of 18 individuals were analyzed; two of them were lost to follow-up. The mean procedure time and injected volume were about 30 min and 6.6 ± 0.9 ml, respectively. The mean surface areas of the glans at baseline and 24 weeks were 20.0 ± 3.5 cm2 and 33.6 ± 5.4 cm2, respectively, representing a mean increase of 68.7{\%} ± 14.0{\%} (P < 0.001). Sixteen individuals (88.9{\%}) were satisfied with the outcomes, and none were dissatisfied. There were no serious adverse events during the study. Cross-linked dextran gel injection for glans penis augmentation was easy and showed a significant augmentative effect on the glans penis, good durability, and was well tolerated without serious adverse events. Therefore, cross-linked dextran gel injection may be an effective, new technique for glans penis augmentation.",
keywords = "cosmetic technique, dermal fllers, dextran, glans penis",
author = "Yang, {Dae Yul} and Kyungtae Ko and Lee, {Seong Ho} and Moon, {Du Geon} and Kim, {Jong Wook} and Lee, {Won Ki}",
year = "2018",
month = "1",
day = "1",
doi = "10.4103/aja.aja_1_17",
language = "English",
volume = "20",
pages = "80--84",
journal = "Asian Journal of Andrology",
issn = "1008-682X",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Efficacy and safety of newly developed cross-linked dextran gel injection for glans penis augmentation with a novel technique

AU - Yang, Dae Yul

AU - Ko, Kyungtae

AU - Lee, Seong Ho

AU - Moon, Du Geon

AU - Kim, Jong Wook

AU - Lee, Won Ki

PY - 2018/1/1

Y1 - 2018/1/1

N2 - There is no safe and effective standard method for glans penis augmentation. Furthermore, there has been scant research on glans penis augmentation due to a poor understanding of glans anatomy, technical difficulty, and a lack of suitable substances for augmentation. Cross-linked dextran gel is a newly developed filler for soft-tissue augmentation. We evaluated the efficacy and safety of using a novel technique to inject cross-linked dextran gel for glans penis augmentation during a 24-week follow-up study. This prospective, single-arm, multicenter study enrolled twenty healthy adult men who underwent glans penis augmentation between June and August 2013. Cross-linked dextran gel was injected into the glans penis using a simple and easy technique. The sizes of the glans penis and individual satisfaction were assessed. Any adverse event was also reported. A total of 18 individuals were analyzed; two of them were lost to follow-up. The mean procedure time and injected volume were about 30 min and 6.6 ± 0.9 ml, respectively. The mean surface areas of the glans at baseline and 24 weeks were 20.0 ± 3.5 cm2 and 33.6 ± 5.4 cm2, respectively, representing a mean increase of 68.7% ± 14.0% (P < 0.001). Sixteen individuals (88.9%) were satisfied with the outcomes, and none were dissatisfied. There were no serious adverse events during the study. Cross-linked dextran gel injection for glans penis augmentation was easy and showed a significant augmentative effect on the glans penis, good durability, and was well tolerated without serious adverse events. Therefore, cross-linked dextran gel injection may be an effective, new technique for glans penis augmentation.

AB - There is no safe and effective standard method for glans penis augmentation. Furthermore, there has been scant research on glans penis augmentation due to a poor understanding of glans anatomy, technical difficulty, and a lack of suitable substances for augmentation. Cross-linked dextran gel is a newly developed filler for soft-tissue augmentation. We evaluated the efficacy and safety of using a novel technique to inject cross-linked dextran gel for glans penis augmentation during a 24-week follow-up study. This prospective, single-arm, multicenter study enrolled twenty healthy adult men who underwent glans penis augmentation between June and August 2013. Cross-linked dextran gel was injected into the glans penis using a simple and easy technique. The sizes of the glans penis and individual satisfaction were assessed. Any adverse event was also reported. A total of 18 individuals were analyzed; two of them were lost to follow-up. The mean procedure time and injected volume were about 30 min and 6.6 ± 0.9 ml, respectively. The mean surface areas of the glans at baseline and 24 weeks were 20.0 ± 3.5 cm2 and 33.6 ± 5.4 cm2, respectively, representing a mean increase of 68.7% ± 14.0% (P < 0.001). Sixteen individuals (88.9%) were satisfied with the outcomes, and none were dissatisfied. There were no serious adverse events during the study. Cross-linked dextran gel injection for glans penis augmentation was easy and showed a significant augmentative effect on the glans penis, good durability, and was well tolerated without serious adverse events. Therefore, cross-linked dextran gel injection may be an effective, new technique for glans penis augmentation.

KW - cosmetic technique

KW - dermal fllers

KW - dextran

KW - glans penis

UR - http://www.scopus.com/inward/record.url?scp=85040081633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040081633&partnerID=8YFLogxK

U2 - 10.4103/aja.aja_1_17

DO - 10.4103/aja.aja_1_17

M3 - Article

C2 - 28303807

AN - SCOPUS:85040081633

VL - 20

SP - 80

EP - 84

JO - Asian Journal of Andrology

JF - Asian Journal of Andrology

SN - 1008-682X

IS - 1

ER -